Tango Therapeutics TNGX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $112.28M+61.5% | $69.53M+4.7% | $66.39M+10.7% | $59.97M-58.0% | ||
| $230.86M+22.5% | $188.39M-30.4% | $270.5M-11.6% | $306.17M-10.6% | ||
| $428K-52.4% | $900K+5.1% | $856K+51.0% | $567K0.0% | ||
| $10.19M+20.9% | $8.43M-4.2% | $8.8M+33.9% | $6.57M+45.5% | ||
| $353.76M+32.8% | $266.34M-23.1% | $346.54M-7.7% | $375.27M-23.8% | ||
| $6.87M-15.2% | $8.1M-18.2% | $9.91M-9.0% | $10.88M+125% | ||
| $10.54M+26.0% | $8.36M+39.6% | $5.99M+62.7% | $3.68M+45.6% | ||
| $35.62M-9.8% | $39.48M-9.3% | $43.51M-7.2% | $46.89M+3,639% | ||
| $303K+7,475% | $4K-91.3% | $46K+820% | $5K-73.7% | ||
| $398.69M+26.0% | $316.49M-21.4% | $402.57M-7.8% | $436.47M-12.7% | ||
| $9.05M+1.1% | $8.95M+13.2% | $7.91M+37.9% | $5.74M+55.6% | ||
| $2.74M+11.6% | $2.45M+17.9% | $2.08M+17.6% | $1.77M+17.8% | ||
| $1M-28.6% | $1.4M-22.2% | $1.8M+260% | $500K— | ||
| $21.68M-43.2% | $38.17M-16.9% | $45.94M-17.3% | $55.55M+36.5% | ||
| $30.83M-9.4% | $34.04M-7.6% | $36.84M-6.4% | $39.36M— | ||
| $33.57M— | —— | $36.49M-11.3% | $41.13M+2,637% | ||
| $52.51M-55.1% | $116.98M-21.7% | $149.46M-20.1% | $186.99M+20.3% | ||
| 200M+185,085% | 108K+5.9% | 102K+15.9% | 88K0.0% | ||
| $948.97M+35.4% | $700.63M+12.3% | $624.08M+19.4% | $522.61M+3.1% | ||
| -$603.15M-20.3% | -$501.56M-35.1% | -$371.26M-37.8% | -$269.51M-67.1% | ||
| $224K-33.3% | $336K+80.6% | $186K+105% | -$3.71M-384% | ||
| $346.18M+73.5% | $199.52M-21.2% | $253.11M+1.5% | $249.48M-27.6% | ||
| $398.69M+26.0% | $316.49M-21.4% | $402.57M-7.8% | $436.47M-12.7% | ||
| $230.64M+22.6% | $188.05M-30.4% | $270.31M-12.8% | $309.87M-9.7% | ||
| —— | —— | $32.16M-73.8% | $123M— | ||
| —— | —— | $32.16M-73.8% | $123M— | ||
| —— | $46.02M-23.1% | $59.86M-47.1% | $113.13M-65.7% | ||
| —— | $46.02M-23.1% | $59.86M-47.1% | $113.13M-65.7% | ||
| —— | $39K-80.0% | $195K-94.8% | $3.73M+386% | ||
| —— | —— | $32.16M-73.8% | $123M— | ||
| —— | $46.02M-50.0% | $92.02M-61.0% | $236.13M-28.4% | ||
| —— | $46.02M-23.1% | $59.86M-47.1% | $113.13M-65.7% | ||
| $114.85M+59.3% | $72.1M+3.3% | $69.81M+9.1% | $63.96M-55.9% | ||
| —— | $46.02M-50.0% | $92.02M-61.0% | $236.13M-28.4% | ||
| $230.86M+22.5% | $188.39M-30.4% | $270.5M-11.6% | $306.17M-10.6% | ||
| —— | —— | —— | —— | ||
| $230.86M+22.5% | $188.39M-30.4% | $270.5M-11.6% | $306.17M-10.6% | ||
| $303K+7,475% | $4K-91.3% | $46K+820% | $5K-73.7% | ||
| $230.64M+22.6% | $188.05M-30.4% | $270.31M-12.8% | $309.87M-9.7% | ||
| $35.62M-9.8% | $39.48M-9.3% | $43.51M-7.2% | $46.89M+3,639% | ||
| $35.62M-9.8% | $39.48M-9.3% | $43.51M-7.2% | $46.89M+3,639% | ||
| $303K+7,475% | $4K-91.3% | $46K+820% | $5K-73.7% | ||
| $17.41M+5.7% | $16.47M+3.6% | $15.9M+9.1% | $14.57M+97.9% | ||
| $35.62M-9.8% | $39.48M-9.3% | $43.51M-7.2% | $46.89M+3,639% | ||
| $303K+7,475% | $4K-91.3% | $46K+820% | $5K-73.7% | ||
| $9.05M+1.1% | $8.95M+13.2% | $7.91M+37.9% | $5.74M+55.6% | ||
| $17.76M+7.6% | $16.5M+7.1% | $15.4M-12.0% | $17.5M+76.9% | ||
| $9.05M+1.1% | $8.95M+13.2% | $7.91M+37.9% | $5.74M+55.6% | ||
| $33.57M-8.0% | $36.49M0.0% | $36.49M-11.3% | $41.13M+2,637% | ||
| —— | —— | $161K-93.5% | $2.46M— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 135.9M+26.2% | 107.7M+5.4% | 102.2M+15.9% | 88.2M+0.7% | ||
| $60.72M+2,715% | $2.16M-96.6% | $62.64M-99.7% | $24.27B-52.8% | ||
| $136K+25.9% | $108K+5.9% | $102K+15.9% | $88K0.0% | ||
| —— | $46.02M-50.0% | $92.02M-61.0% | $236.13M-28.4% | ||
| —— | —— | —— | —— | ||
| 20.5M+4.3% | 19.6M+17.2% | 16.7M+29.5% | 12.9M+37.9% | ||
| $224K-40.3% | $375K-1.6% | $381K+1,714% | $21K+2,000% | ||
| $0-100% | $39K-80.0% | $195K-94.8% | $3.73M+386% | ||
| $6.53-11.9% | $7.41+19.3% | $6.21-4.5% | $6.50+16.3% | ||
| $230.64M+22.6% | $188.05M-30.4% | $270.31M-12.8% | $309.87M-9.7% | ||
| $7.42M+27.8% | $5.81M-6.3% | $6.2M-40.9% | $10.49M+89.6% | ||
| $0-100% | $39K-80.0% | $195K-94.8% | $3.73M+386% | ||
| $224K-40.3% | $375K-1.6% | $381K+1,714% | $21K+2,000% | ||
| $230.64M+22.6% | $188.05M-30.4% | $270.31M-12.8% | $309.87M-9.7% | ||
| —— | —— | —— | —— | ||
| $114.85M+59.3% | $72.1M+3.3% | $69.81M+9.1% | $63.96M-55.9% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | ||
| $135.94M+26.2% | $107.73M+5.4% | $102.2M+15.9% | $88.18M+0.7% | ||
| $135.94M+26.2% | $107.73M+5.4% | $102.2M+15.9% | $88.18M+0.7% | ||
| —— | —— | $161K-93.5% | $2.46M— | ||
| —— | $46.02M-23.1% | $59.86M-47.1% | $113.13M-65.7% | ||
| —— | —— | $32.16M-73.8% | $123M— | ||
| —— | $39K+14.7% | $34K-97.3% | $1.27M+65.4% | ||
| —— | $39K-80.0% | $195K-94.8% | $3.73M+386% | ||
| —— | $46.02M-50.0% | $92.02M-61.0% | $236.13M-28.4% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $1.29M-25.7% | $1.74M+34.8% | $1.29M+1.6% | $1.27M+90.2% | ||
| —— | —— | —— | —— | ||
| $20.47M+4.3% | $19.62M+17.2% | $16.73M+29.5% | $12.92M+37.9% | ||
| $6.53-11.9% | $7.41+19.3% | $6.21-4.5% | $6.5+16.3% | ||
| $60.72M+2,715% | $2.16M-96.6% | $62.64M-99.7% | $24.27B-52.8% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 10M0.0% | 10M0.0% | 10M0.0% | 10M0.0% | ||
| 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Tango Therapeutics cover its short-term obligations?
- Its current ratio is 27.38 — current assets exceed current liabilities.
- Where does Tango Therapeutics's balance sheet data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.